| abstract |
O-(5-amino-2-phenylbenzoxazol-7-yl)methyl-3,5-dichloro-L for use in the treatment of a disease in a subject, eg, an allergic disease, an autoimmune disease, an inflammatory disease - Tyrosine, or a pharmaceutical composition comprising a pharmaceutically acceptable salt thereof, is a pharmaceutical composition administered to the subject having a NAT2 gene of Non-Rapid (Slow and/or Intermediate) type. |